Son W-G, Graham T A, Gannon V P J
Population and Public Health Branch, Health Canada, Lethbridge, Alberta T1J 3Z4, Canada.
Clin Diagn Lab Immunol. 2002 Jan;9(1):46-53. doi: 10.1128/cdli.9.1.46-53.2002.
Portions of the intimin genes of Escherichia coli O157:H7 strain E319 and of the enteropathogenic E. coli O127:H6 strain E2348/69 were amplified by PCR and cloned into pET-28a+ expression vectors. The entire 934 amino acids (aa) of E. coli O157:H7 intimin, the C-terminal 306 aa of E. coli O157:H7 intimin, and the C-terminal 311 aa of E. coli O127:H6 intimin were expressed as proteins fused with a six-histidine residue tag (six-His tag) in pET-28a+. Rabbit antisera raised against the six-His tag-full-length E. coli O157:H7 intimin protein fusion cross-reacted in slot and Western blots with outer membrane protein preparations from the majority of enterohemorrhagic and enteropathogenic E. coli serotypes which have the intimin gene. The E. coli strains tested included isolates from humans and animals which produce intimin types alpha (O serogroups 86, 127, and 142), beta1 (O serogroups 5, 26, 46, 69, 111, 126, and 128), gamma 1 (O serogroups 55, 145, and 157), gamma 2 (O serogroups 111 and 103), and epsilon (O serogroup 103) and a nontypeable intimin (O serogroup 80), results based on intimin type-specific PCR assays. Rabbit antisera raised against the E. coli O157:H7 C-terminal fusion protein were much more intimin type-specific than those raised against the full-length intimin fusion protein, but some cross-reaction with other intimin types was also observed for these antisera. In contrast, the monoclonal antibody Intgamma1.C11, raised against the C-terminal E. coli O157 intimin, reacted only with preparations from intimin gamma 1-producing E. coli strains such as E. coli O157:H7.
通过聚合酶链反应(PCR)扩增大肠杆菌O157:H7菌株E319和肠致病性大肠杆菌O127:H6菌株E2348/69的部分intimin基因,并将其克隆到pET-28a+表达载体中。大肠杆菌O157:H7 intimin的完整934个氨基酸(aa)、大肠杆菌O157:H7 intimin的C末端306个aa以及大肠杆菌O127:H6 intimin的C末端311个aa在pET-28a+中表达为与六个组氨酸残基标签(六个His标签)融合的蛋白质。针对六个His标签-全长大肠杆菌O157:H7 intimin蛋白融合物产生的兔抗血清在斑点印迹和蛋白质印迹中与大多数具有intimin基因的肠出血性和肠致病性大肠杆菌血清型的外膜蛋白制剂发生交叉反应。所测试的大肠杆菌菌株包括来自人和动物的分离株,这些分离株产生α型(O血清群86、127和142)、β1型(O血清群5、26、46、69、111、126和128)、γ1型(O血清群55、145和157)、γ2型(O血清群111和103)和ε型(O血清群103)的intimin以及一种不可分型的intimin(O血清群80),这些结果基于intimin类型特异性PCR检测。针对大肠杆菌O157:H7 C末端融合蛋白产生的兔抗血清比针对全长intimin融合蛋白产生的抗血清具有更高的intimin类型特异性,但这些抗血清也观察到与其他intimin类型有一些交叉反应。相比之下,针对大肠杆菌O157 intimin C末端产生的单克隆抗体Intgamma1.C11仅与产生γ1型intimin的大肠杆菌菌株(如大肠杆菌O157:H7)的制剂发生反应。